We are live on ! Find out more
Westfield Capital Management

Westfield Capital Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 49.45%
This Fund
S&P 500
This Quarter Est. Return
+11.42%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$11.6B
AUM Growth
+$243M
Cap. Flow
-$770M
Cap. Flow %
-6.61%
Top 10 Hldgs %
17.24%
Holding
303
New
50
Increased
66
Reduced
133
Closed
45

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$102M
2
SPGI icon
S&P Global
SPGI
+$82.9M
3
ICE icon
Intercontinental Exchange
ICE
+$72.4M
4
NKE icon
Nike
NKE
+$55.5M
5
AVY icon
Avery Dennison
AVY
+$49.6M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$95.4M
2
TJX icon
TJX Companies
TJX
+$94.8M
3
CB icon
Chubb
CB
+$87.2M
4
INTC icon
Intel
INTC
+$80.1M
5
UNP icon
Union Pacific
UNP
+$73.6M

Sector Composition

Rank Sector Weight
1 Healthcare 18.27%
2 Technology 17.63%
3 Consumer Discretionary 13.42%
4 Industrials 12.91%
5 Communication Services 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MACK
301
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-1,153,163
Closed -$37M
ARIA
302
DELISTED
Ariad Pharmaceuticals Inc
ARIA
-4,957,058
Closed -$61.7M
MHG
303
DELISTED
Marine Harvest ASA
MHG
-351,965
Closed -$6.38M

Similar funds

Westfield Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Westfield Capital Management held 303 positions worth $11.6B, up 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Westfield Capital Management withdrew a net $770M in Q1 2017, closing 45 positions and reducing 133 holdings. Its most notable exit was TJX Companies, an estimated $94.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Westfield Capital Management opened a new position in Biogen worth $98.2M.

  • Westfield Capital Management's largest Q1 2017 buy was Biogen: 359,107 shares worth $98.2M.
  • Westfield Capital Management added most to Walt Disney in Q1 2017, an estimated $48.8M increase.
  • Westfield Capital Management's biggest Q1 2017 reduction was Gilead Sciences, cutting an estimated $95.4M.
  • Westfield Capital Management fully exited TJX Companies in Q1 2017, selling an estimated $94.8M.
  • Westfield Capital Management's ten largest holdings make up 17% of its $11.6B portfolio in Q1 2017.
  • Westfield Capital Management opened 50 new positions and closed 45 in Q1 2017.
  • Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $11.6B.

Based on Westfield Capital Management's 13F filing for Q1 2017, filed 12 May 2017.